These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Overview of ITP treatment modalities in children. Buchanan GR Blut; 1989 Jul; 59(1):96-104. PubMed ID: 2665875 [TBL] [Abstract][Full Text] [Related]
25. Treatment of immune thrombocytopenic purpura in children : current concepts. Shad AT; Gonzalez CE; Sandler SG Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997 [TBL] [Abstract][Full Text] [Related]
26. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)]. Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732 [TBL] [Abstract][Full Text] [Related]
27. "Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children. Sundin M; Marits P; Nierkens S; Kolios AGA; Nilsson J J Pediatr Hematol Oncol; 2019 Mar; 41(2):155-157. PubMed ID: 29620681 [TBL] [Abstract][Full Text] [Related]
28. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. Bussel JB; Schulman I; Hilgartner MW; Barandun S J Pediatr; 1983 Oct; 103(4):651-4. PubMed ID: 6684679 [TBL] [Abstract][Full Text] [Related]
29. High-dose intravenous gammaglobulin therapy for passive immune thrombocytopenia in the neonate. Chirico G; Duse M; Ugazio AG; Rondini G J Pediatr; 1983 Oct; 103(4):654-5. PubMed ID: 6684680 [No Abstract] [Full Text] [Related]
30. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease. Bussel JB; Hilgartner MW Br J Haematol; 1984 Jan; 56(1):1-7. PubMed ID: 6367804 [TBL] [Abstract][Full Text] [Related]
32. High-dose immunoglobulin therapy in four patients with onyalai. Hesseling PB Trans R Soc Trop Med Hyg; 1991; 85(1):131-2. PubMed ID: 1906204 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura. Pruemer J Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S4-10. PubMed ID: 19139489 [TBL] [Abstract][Full Text] [Related]
35. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. Blanchette VS; Luke B; Andrew M; Sommerville-Nielsen S; Barnard D; de Veber B; Gent M J Pediatr; 1993 Dec; 123(6):989-95. PubMed ID: 8229536 [TBL] [Abstract][Full Text] [Related]